Evidence of increased oxidative damage in subjects with mild cognitive impairment

J N Keller1, F A Schmitt, S W Scheff

  • 1Department of Anatomy, University of Kentucky, Lexington 40536-0230, USA. Jnkell0@pop.uky.edu

Neurology
|April 13, 2005
PubMed
Abstract

Insights

Oxidative damage is present in the brains of individuals with mild cognitive impairment (MCI). This damage, indicated by elevated biomarkers, may be an early event in the progression of Alzheimer disease (AD).

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Mild cognitive impairment (MCI) is a precursor to Alzheimer disease (AD).
  • Oxidative damage is implicated in neurodegenerative processes.
  • Understanding early pathological changes in MCI is crucial for AD prevention.

Purpose of the Study:

  • To investigate the presence and extent of oxidative damage in the brains of individuals with MCI.
  • To compare oxidative damage markers in MCI and early AD brains versus normal controls.
  • To explore the relationship between oxidative damage and cognitive decline.

Main Methods:

  • Analysis of protein carbonyls, thiobarbituric acid-reactive substances (TBARS), and malondialdehyde in brain tissue (superior and middle temporal gyri, cerebellum).
  • Comparison of tissue samples from individuals with MCI, early AD, and normal controls with short postmortem intervals.
  • Correlation of oxidative damage markers with neuritic/diffuse plaques and verbal memory performance.

Main Results:

  • Significantly elevated levels of protein carbonyls (~25%), malondialdehyde (~60%), and TBARS (~210%) were found in the SMTG of individuals with MCI and early AD compared to controls.
  • Increased TBARS levels correlated with the number of neuritic plaques.
  • Higher protein carbonyl levels were associated with poorer delayed verbal memory performance.

Conclusions:

  • Oxidative damage is evident in the brains of individuals with mild cognitive impairment.
  • These findings suggest that oxidative damage may represent an early pathological event in the development and progression of Alzheimer disease.
  • Targeting oxidative stress could be a potential therapeutic strategy for MCI and AD.

Related Concept Videos

Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...